Published in Ann Rheum Dis on September 03, 2007
The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review. Rheumatol Int (2011) 0.93
Simvastatin-induced dermatomyositis in a 50-year-old man. BMJ Case Rep (2011) 0.79
Statin-associated polymyositis following omeprazole treatment. Clin Med Res (2013) 0.77
Increased Cumulative Incidence of Dermatomyositis in Ulcerative Colitis: a Nationwide Cohort Study. Sci Rep (2016) 0.75
Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of Statins. Clin Lab Med (2016) 0.75
Prescription of drugs during pregnancy in France. Lancet (2000) 4.12
Economic evaluation of surgically trained assistant medical officers in performing major obstetric surgery in Mozambique. BJOG (2007) 2.37
Stenosis of the lumbar spinal canal in vertebral ankylosing hyperostosis. Spine (Phila Pa 1976) (1992) 2.07
Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain (2000) 2.06
Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database. Pharmacoepidemiol Drug Saf (2006) 1.96
Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol (2008) 1.81
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol (2004) 1.76
Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis. Clin Exp Rheumatol (2004) 1.66
[Late myopathies located at the spinal muscles: a cause of acquired lumbar kyphosis in adults]. Rev Rhum Mal Osteoartic (1991) 1.59
Sweet's syndrome revealing relapsing polychondritis. Int J Dermatol (2004) 1.58
Current status of cytogenetic procedures to detect and quantify previous exposures to radiation. Mutat Res (1988) 1.55
The effect of elbow position on the range of supination and pronation of the forearm. J Hand Surg Eur Vol (2008) 1.54
[Pharmacovigilance of self-medication]. Therapie (1997) 1.54
Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis. AJNR Am J Neuroradiol (1999) 1.54
An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer. Rev Port Pneumol (2008) 1.53
Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis. Ann Rheum Dis (1998) 1.51
Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum (1999) 1.50
Pharmacological treatment of acute otitis media in children. A comparison among seven locations: Tenerife, Barcelona and Valencia (Spain), Toulouse (France), Smolensk (Russia), Bratislava (Slovakia) and Sofia (Bulgaria). Eur J Clin Pharmacol (2004) 1.49
[Unilateral choroid metastasis revealing bronchial adenocarcinoma in a woman]. Presse Med (1995) 1.40
Neurosensory adverse effects after phenylbutazone and misoprostol combined treatment. Lancet (1989) 1.39
[Should long-term corticosteroid treatment be given in rheumatoid arthritis?]. Rev Rhum Ed Fr (1993) 1.39
[The use of clomiphene citrate in ambulatory medicine practice in the Midi-Pyrénées area: compliance to national guidelines applicable to infertility diagnosis and to prescription and monitoring rules applicable to clomiphene citrate treatments]. Gynecol Obstet Fertil (2004) 1.39
[Peripheral inflammatory rheumatism during Horton's disease]. Presse Med (1990) 1.38
New-onset acute heart failure and ventricular tachycardia after therapy with a tumor necrosis factor antagonist. Clin Exp Rheumatol (2005) 1.38
Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 1.36
Water drinking and the heart. Lancet (1999) 1.34
Antivertigo medications and drug-induced vertigo. A pharmacological review. Drugs (1995) 1.33
Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals. Br J Clin Pharmacol (2002) 1.27
Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med (1999) 1.27
Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine. Clin Neuropharmacol (1986) 1.25
Sleep attacks and Parkinson's disease treatment. Lancet (2000) 1.25
Isolation from Candida albicans of a functional homolog of the Saccharomyces cerevisiae KRE1 gene, which is involved in cell wall beta-glucan synthesis. J Bacteriol (1991) 1.24
Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer (2005) 1.24
The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients. Brain (1997) 1.23
Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant (2010) 1.23
Morphological analyses of paraspinal muscles: comparison of progressive lumbar kyphosis (camptocormia) and narrowing of lumbar canal by disc protrusions. Neuromuscul Disord (1994) 1.20
Adrenergic supersensitivity in parkinsonians with orthostatic hypotension. Eur J Clin Invest (1990) 1.18
Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience (2008) 1.18
Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals. Br J Clin Pharmacol (2000) 1.18
Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen. J Immunol Methods (1991) 1.16
Effects of yohimbine on submaxillary salivation in dogs. Br J Pharmacol (1989) 1.15
Developmental regulation of the synthesis of proteins encoded by stored mRNA in radish embryos. Plant Physiol (1984) 1.13
Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol (1992) 1.13
Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients. Rev Rhum Engl Ed (1999) 1.11
Health status and health services utilization of Canada's immigrant and non-immigrant populations. Can Public Policy (2000) 1.09
Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems. Brain (1989) 1.09
Pharmacological prospects for alpha 2-adrenoceptor antagonist therapy. Trends Pharmacol Sci (1992) 1.09
Hepatitis C virus. BMJ (1991) 1.08
Malnutrition and falls. Lancet (1990) 1.08
Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur J Clin Pharmacol (2009) 1.08
Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers. Neurology (2002) 1.07
Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database. Fundam Clin Pharmacol (2007) 1.07
Yohimbine increases human salivary secretion. Br J Clin Pharmacol (1989) 1.07
Spondylodiscitis due to Aerococcus urinae: a first report. Scand J Infect Dis (2003) 1.07
Thyroid function in respiratory distress syndrome (RDS) of the newborn. Pediatrics (1974) 1.07
Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody. Br J Dermatol (2009) 1.07
[Primary camptocormia is a para-vertebral myopathy]. Rev Rhum Ed Fr (1994) 1.06
The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue. Int J Obes (Lond) (2011) 1.06
Effect of a complex environmental mixture from coal tar containing polycyclic aromatic hydrocarbons (PAH) on the tumor initiation, PAH-DNA binding and metabolic activation of carcinogenic PAH in mouse epidermis. Carcinogenesis (2001) 1.06
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog. J Pharmacol Exp Ther (1994) 1.04
Macrophage gene expression is related to obesity and the metabolic syndrome in human subcutaneous fat as well as in visceral fat. Diabetologia (2011) 1.03
Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor. Br J Pharmacol (1997) 1.03
The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms. J Pharmacol Exp Ther (1992) 1.03
Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs. Clin Exp Dermatol (2008) 1.03
Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia. Brain (1998) 1.03
Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours. Ann Oncol (2013) 1.03
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease. Mov Disord (2001) 1.01
Square wave jerks in parkinsonian syndromes. J Neurol Neurosurg Psychiatry (1991) 1.01
The family heart dietary intervention program: community response and characteristics of joining and nonjoining families. Prev Med (1984) 1.01
Odorous urine in man after asparagus. Br J Clin Pharmacol (1989) 1.00
[General practice management of obstructive sleep apnea in the Midi-Pyrénées]. Rev Mal Respir (2007) 1.00
Yohimbine increases submaxillary kallikrein release into the saliva in dogs: evidence for alpha 2-adrenoceptor-mediated inhibition of cholinergic pathways. Br J Pharmacol (1991) 0.99
Smooth muscle tumors associated with X-linked Alport syndrome: carrier detection in females. Kidney Int (1995) 0.99
Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management. Drugs Aging (2001) 0.99
Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res (1992) 0.99
Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension. Clin Auton Res (1992) 0.99
[Drug-induced hiccup: a review of the France pharmacologic vigilance database]. Therapie (1999) 0.99
Dietary chlorophyllin is a potent inhibitor of aflatoxin B1 hepatocarcinogenesis in rainbow trout. Cancer Res (1995) 0.99
The incidence of concha bullosa and the correlation with nasal septal deviation. B-ENT (2008) 0.99
Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E. Emerg Infect Dis (2015) 0.98
Factors influencing range of motion after total knee arthroplasty. Iran Red Crescent Med J (2012) 0.98
A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol (1996) 0.97
Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course. Br J Clin Pharmacol (2007) 0.97
Quantitative inter-relationships between aflatoxin B1 carcinogen dose, indole-3-carbinol anti-carcinogen dose, target organ DNA adduction and final tumor response. Carcinogenesis (1989) 0.97
Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. J Neurol Neurosurg Psychiatry (1994) 0.97
The Vicia faba leghemoglobin gene VfLb29 is induced in root nodules and in roots colonized by the arbuscular mycorrhizal fungus Glomus fasciculatum. Mol Plant Microbe Interact (1997) 0.96
[Drug vigilance: opinion survey among residents of a university hospital]. Therapie (1995) 0.96
New insights of HLA class I association to Behçet's disease in Portuguese patients. Tissue Antigens (2008) 0.95
Analysis of patients' narratives posted on social media websites on benfluorex's (Mediator® ) withdrawal in France. J Clin Pharm Ther (2013) 0.94
L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers. Clin Neuropharmacol (1999) 0.94